BBHVanEck Biotech ETF
Grow my money#927 of 2944 for Grow my money
Seeks to replicate the price and yield performance of the MVIS US Listed Biotech 25 Index.
VanEck · Since 2011 (14 years)
Annual Cost
0.35%
#1517 out of 5,332 ETFs
Fund Size
$372M
#1669 out of 5,332 ETFs
Dividend Yield
0.51%
Track Record
14 years
#964 out of 5,332 ETFs
Performance
1 Year
+20.6%
3 Years
+5.7%
5 Years
-0.4%
What's inside
Asset class
Region
Focus
Biotech & Genomics
Asset allocation
Stocks
99.9%
Cash
0.1%
Sector breakdown
Healthcare
100.0%
Top holdings
Amgen IncAMGN14.8%
Gilead Sciences IncGILD14.7%
Vertex Pharmaceuticals IncVRTX8.2%
Regeneron Pharmaceuticals IncREGN7.5%
argenx SE ADRARGX5.2%
Insmed IncINSM4.4%
IQVIA Holdings IncIQV4.3%
Alnylam Pharmaceuticals IncALNY4.0%
Biogen IncBIIB3.9%
United Therapeutics CorpUTHR3.9%
Risk profile
Volatility (1Y)
20.5%
High
Max drawdown
-39.9%
Worst peak-to-trough loss
Sharpe (3Y)
0.20
Below average
Sortino (3Y)
0.28
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05